The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT
Open accessAbstract
AIMS: Plasma levels of individual neurohormones (NH) have been proposed as reliable indicators for risk stratification of patients with heart failure (HF). Mainly because of small sample size, the predictive value of different NH has never been compared, while taking into account demographic, clinical and echocardiographic markers of risk in HF. METHODS AND RESULTS: Plasma brain natriuretic peptide (BNP), norepinephrine (NE), renin activity (PRA), aldosterone (aldo) and endothelin were measured in 4300 patients before randomization in Val-HeFT. Univariate and multivariate Cox proportional hazard analyses were performed to investigate the relationship between NH and two primary study outcomes, mortality and combined mortality and morbidity (M/M). Higher baseline values for all NH were related to mortality and M/M, with univariate hazard ratios ranging from 1.13 [95% CI 0.99-1.30] (aldo) to 2.47 [2.13-2.87] (BNP) for mortality, and from 1.24 [1.11-1.39] (aldo) to 2.56 [2.28-2.89] (BNP) for M/M. In multivariate analyses, BNP had the strongest association with outcome, followed by NE and PRA. Patients with more activation of renin-angiotensin-aldosterone system tended to show greater benefit from valsartan; but the trend was not statistically significant. CONCLUSION: All the NHs evaluated in 4300 patients with stable moderate to severe HF were found to be significant markers of outcome, despite therapy with ACEi, BB and randomization to an angiotensin receptor blocker or placebo. Several of these markers have been implicated as contributors to progression of HF, but BNP, which is thought to be protective, was the most powerful indicator for poor outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Duc, P., Omland, T., Storrow, A. B., Abraham, W. T., Wu, A. H. B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020233 · Cited by 3,362
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,199
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Plasma brain natriuretic peptide concentration: impact of age and gender
Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R., & Burnett, J. C. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02059-4 · Cited by 1,138
Plasma norepinephrine in congestive heart failure
Thomas, J. A., & Marks, B. H. (1978) · The American Journal of Cardiology · doi:10.1016/0002-9149(78)90162-5 · Cited by 920
McCullough, P. A., Nowak, R. M., McCord, J., Hollander, J. E., Herrmann, H. C., Steg, P. G., Duc, P., Westheim, A., Omland, T., Knudsen, C. W., et al. (2002) · Circulation · doi:10.1161/01.cir.0000025242.79963.4c · Cited by 879
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Bühler, F. R., Laragh, J. H., Baer, L., Vaughan, E. D., & Brunner, H. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197212142872401 · Cited by 718
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Endothelin in human congestive heart failure.
Wei, C. M., Lerman, A., Rodeheffer, R. J., McGregor, C. G., Brandt, R. R., Wright, S., Heublein, D. M., Kao, P. C., Edwards, W. D., & Burnett, J. C. (1994) · Circulation · doi:10.1161/01.cir.89.4.1580 · Cited by 586
Goldstein, D. S., Feuerstein, G., Izzo, J. L., Kopin, I. J., & Keiser, H. R. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90139-9 · Cited by 467
Maeda, K., Tsutamoto, T., Wada, A., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00912-8 · Cited by 418
Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure
Koglin, J., Pehlivanli, S., Schwaiblmair, M., Vogeser, M., Cremer, P., & vonScheidt, W. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01672-2 · Cited by 404
Francis, G. S., Cohn, J. N., Johnson, G., Rector, T. S., Goldman, S., & Simon, A. (1993) · PubMed · Cited by 354
Benedict, C. R., Shelton, B., Johnstone, D. E., Francis, G., Greenberg, B., Konstam, M., Probstfield, J. L., & Yusuf, S. (1996) · Circulation · doi:10.1161/01.cir.94.4.690 · Cited by 353
Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
STAESSEN, J., LIJNEN, P., FAGARD, R., VERSCHUEREN, L. J., & AMERY, A. (1981) · Journal of Endocrinology · doi:10.1677/joe.0.0910457 · Cited by 339
Tissue angiotensin system in cardiovascular medicine. A paradigm shift?
Dzau, V. J., & Re, R. (1994) · Circulation · doi:10.1161/01.cir.89.1.493 · Cited by 301
Latini, R., Masson, S., Anand, I., Judd, D., Maggioni, A. P., Chiang, Y.-T., Bevilacqua, M., Salio, M., Cardano, P., Dunselman, P. H. J. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000036747.68104.ac · Cited by 291
Self-citationRouleau, J.-L., Packer, M., Moyé, L., de Champlain, J., Bichet, D., Klein, M., Rouleau, J. R., Sussex, B., Arnold, J. M., Sestier, F., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90001-9 · Cited by 285
Francis, G. S., Cohn, J. N., Johnson, G. R., Rector, T. S., Goldman, S., & Simon, A. (1993) · Circulation · Cited by 247
Benedict, C. R., Johnstone, D. E., Weiner, D. H., Bourassa, M. G., Bittner, V., Kay, R., Kirlin, P., Greenberg, B., Kohn, R. M., Nicklas, J. M., et al. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90385-9 · Cited by 225
Hobbs, F. D. R., Davis, R. C., Roalfe, A. K., Hare, R., Davies, M. K., & Kenkre, J. E. (2002) · BMJ · doi:10.1136/bmj.324.7352.1498 · Cited by 220
Neurohumoral Prediction of Benefit From Carvedilol in Ischemic Left Ventricular Dysfunction
Richards, A. M., Doughty, R., Nicholls, M. G., Macmahon, S., Ikram, H., Sharpe, N., Espiner, E. A., Frampton, C., & Yandle, T. G. (1999) · Circulation · doi:10.1161/01.cir.99.6.786 · Cited by 212
Ishii, J., Nomura, M., Nakamura, Y., Naruse, H., Mori, Y., Ishikawa, T., Ando, T., Kurokawa, H., Kondo, T., Nagamura, Y., et al. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02341-4 · Cited by 183
White, M., Yusuf, S., McKelvie, R. S., Pericak, D., Young, J. B., Latini, R., Pogue, J., Burns, R. J., Probstfield, J. L., Tsuyuki, R. T., et al. (2000) · Circulation · Cited by 183
Self-citationNew Therapeutic Options in Congestive Heart Failure: Part I
McMurray, J., & Pfeffer, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000014763.63528.9d · Cited by 170
Asano, K., Dutcher, D. L., Port, J. D., Minobe, W. A., Tremmel, K. D., Roden, R. L., Bohlmeyer, T. J., Bush, E. W., Jenkin, M. J., Abraham, W. T., et al. (1997) · Circulation · doi:10.1161/01.cir.95.5.1193 · Cited by 168
Surrogate end points in heart failure
Anand, I. S., Florea, V. G., & Fisher, L. D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01773-4 · Cited by 153
Cohn, J. N., Tognoni, G., Glazer, R. D., Spormann, D., & Hester, A. (1999) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(99)90038-6 · Cited by 146
Luchner, A., Burnett, J. C. J., Jougasaki, M., Hense, H., Riegger, G. A. J., & Schunkert, H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00478-1 · Cited by 133
Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction
Benedict, C. R., Francis, G. S., Shelton, B. J., Johnstone, D. E., Kubo, S. H., Kirlin, P. C., Nicklas, J. M., Liang, C., Konstam, M. A., Greenberg, B., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80748-6 · Cited by 110
New Therapeutic Options in Congestive Heart Failure
McMurray, J. J. V., & Pfeffer, M. A. (2002) · Circulation · doi:10.1161/01.cir.0000014771.38666.22 · Cited by 110
Plasma brain natriuretic peptide concentration: impact of age and gender
Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R., & Burnett, J. C. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)01026-7 · Cited by 102
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
(2002) · New England Journal of Medicine · doi:10.1056/nejm200210033471426 · Cited by 72
The role of neurohormonal activation in chronic heart failure and postmyocardial infarction
Sigurðsson, A. F., & Swedberg, K. B. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90558-x · Cited by 70
Fujimura, M., Yasumura, Y., Ishida, Y., Nakatani, S., Komamura, K., Yamagishi, M., & Miyatake, K. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)80004-4 · Cited by 53
Role of brain natriuretic peptide in the diagnosis and management of heart failure: Current concepts
Latini, R., Masson, S., Angelis, N. D., & Anand, I. S. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.0805288 · Cited by 48
Self-citationSympathetic Nervous System in Heart Failure
Cohn, J. N. (2002) · Circulation · doi:10.1161/01.cir.0000037105.14195.b6 · Cited by 23
Smith, R. F., Germanson, T., Judd, D., et al. (2000) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(00)90011-3 · Cited by 8
Atenolol and chlorthalidone on blood pressure, heart rate, and plasma renin activity in hypertension
Teeuw, A. H., Leenen, F. H. H., Geyskes, G. G., et al. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253294 · Cited by 7
Cited by
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., Anand, I., Maggioni, A., Burton, P., Sullivan, M. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.584102 · Cited by 2,021
Ronco, C., Haapio, M., House, A. A., Anavekar, N., & Bellomo, R. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.051 · Cited by 1,883
Braunwald, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800239 · Cited by 1,257
Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp507 · Cited by 1,104
Latini, R., Masson, S., Anand, I. S., Missov, E., Carlson, M., Vago, T., Angelici, L., Barlera, S., Parrinello, G., Maggioni, A. P., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.655076 · Cited by 709
Self-citation
Metadata
- Authors
- Latini, R.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02
- Volume
- 25
- Issue
- 4
- Pages
- 292-299
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2026881482
- Cited by
- 344
- References
- 46
- FWCI
- 16.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.